Special Presentation: Exercise After Prostate Cancer: Active Surveillance and Beyond

Special Presentation: Exercise After Prostate Cancer: Active Surveillance and Beyond

On December 1st, we had Dr. Kerry Courneya (Professor, Faculty of Kinesiology, Sport, and Recreation at University of Alberta) give a talk to our AS group titled “Exercise After Prostate Cancer: Active Surveillance and Beyond

Dr. Courneya had one message: Don’t take your cancer laying down.

He maintained that research has shown “exercise is the single most important thing” a cancer patient can do—even more important than diet.

His research has shown patients with prostate cancer (low-risk to high-risk), lymphatic cancer, and other cancers benefit from exercise.

The most recent study by his group in Edmonton, appearing in JAMA Oncology, showed for the first time that High Impact Intensity Training–bursts of exercise rather than a continuous approach—can help suppress the growth of prostate cancer cells in men on active surveillance. (https://jamanetwork.com/journals/jamaoncology/fullarticle/2783273)

The ERASE study was the first randomized controlled trial to examine the effects of exercise in men with prostate cancer on AS.

There’s more to the exercise story than suppressing prostate cancer. The biggest risk to men with low-risk prostate cancer is heart disease. The study showed that not only does exercise suppress prostate cancer cells but it also helps with cardiac measures.

He said also exercise relieves anxiety and depression, helping men stay on AS longer.

“Exercise is a win-win.” he said.

Short exercise videos can also be found on Pfizer’s site “This Is Living With Cancer” .

Watch here:

 

To view the slides from this presentation, click here.

For information on our peer-led video chat ACTIVE SURVEILLANCE PROSTATE CANCER VIRTUAL SUPPORT GROUP, click here.

To SIGN UP for the Group or any other of our AnCan Virtual Support groups, visit our Contact Us page.

 

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 23, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 23, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 15, 2021

All AnCan’s groups are free and drop-in – join us in person sometime! You can find out more about this and our other 10 monthly prostate cancer groups at https://ancan.org/prostate-cancer/

To sign up to receive a weekly Reminder/Newsletter for this Group or others, go to https://ancan.org/contact-us/

Editor’s Pick: AnCan is honored with the first time presence of a PCa doyen this week. Even he is overshadowed by conversation between two men with 60+ chemo treatments between them! (rd)

Topics Discussed

Snuffy lives through this PCa elder; testosterone supplementation; keep an eye on bone densitty; lo-fat abiraterone protocol; cryo alternative for spot Tx of lesion; GERD effects seveal of our guys; cabaziatxel + carboplatin protocol for small cell/NE disease; CEA as a marker; TP53 + PTEN cast suspicion on PCa type; diet may slow growth; is AUS causing fevers?; comparing notes on mutliple chemotherapies; drug holidays; lesions disappear with treatment …. but another shows up.

Chat Log

Larry Fish (to Everyone): 4:15 PM: lupron before casodex?

Joe Gallo (to Organizer(s) Only): 4:16 PM: PSMA?

Larry Fish (to Everyone): 4:18 PM: did they try stopping casosex?

Herb Geller (to Organizer(s) Only): 4:19 PM: Bless him! Getting tooth implants at 89!

Jake (to Organizer(s) Only): 4:20 PM: Is that BAT?

Len Sierra (to Organizer(s) Only): 4:20 PM: No, Andro-gel.

Herb Geller (to Organizer(s) Only): 4:20 PM: Its a modified BAT but it depends upon the dose of andro-gel

Jake (to Organizer(s) Only): 4:21 PM: thanks

AnCan – rick (to Organizer(s) Only): 4:24 PM: Not really BAT -BAT uses extremes and swamps AR receptors. This is a crazy Snuffy protocol

Pat Martin (to Everyone): 4:25 PM: Any genetic testing?

AnCan – rick (to Everyone): 4:26 PM: This Testosterone Tx is highly controversial!!

Jimmy Greenfield (Private): 4:27 PM: Snuffy Myers has left quite a footprint! I almost feel like I know him.

AnCan – rick (to Jimmy Greenfield): 4:28 PM: Some crazy ideas and some that proved viable

Dennis Correia (to Everyone): 4:51 PM: Journal of Clinical oncology March 28, 2018 for info the Abi low dose with low fat breakfast.

Len Sierra (to Everyone): 4:51 PM: From Dr. Russell Szmulewitz, (U Chicago) director of the clinical trial showing equivalent effectiveness of Zytiga with food at ¼ the dose with a low fat meal. Abiraterone, approved in 2011 for the treatment of metastatic prostate cancer, has a “food effect” that is greater than any other marketed drug. The amount of abiraterone that gets absorbed and enters the blood stream can be multiplied four or five times if the drug is swallowed with a low-fat meal (7 percent fat, about 300 calories). That can increase to 10 times with a high-fat meal (57 percent fat, 825 calories).

Pat Martin (to Everyone): 4:52 PM: I was under the impression that the docs did not think the patients would follow precise instructions.

Jake (to Organizer(s) Only): 4:56 PM: omeprazole (Zantac?) might be the answer

Joe Gallo (to Organizer(s) Only): 4:57 PM: Prilosec

Jake (to Organizer(s) Only): 4:58 PM: right! thanks Joe.

Herb Geller (to Organizer(s) Only): 5:03 PM: I just read an article that CEA with PC is a very bad prognostic factor

Len Sierra (to Organizer(s) Only): 5:04 PM: I agree, Herb.

Herb Geller (to Organizer(s) Only): 5:05 PM: Although another paper says there is no correlation with OS. So no real data.

Herb Geller (to Everyone): 5:14 PM: Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update Abiraterone 250 mg daily with a low-fat breakfast has been examined as an alternative to abiraterone 1,000 mg on an empty stomach for men with metastatic castration-resistant prostate cancer (CRPC) and was shown in a small phase II trial to be noninferior based on the PSA response rate over 12 weeks…….. read more at https://ascopubs.org/doi/pdf/10.1200/JCO.20.03256

Walter Dardenne (to Everyone): 5:51 PM: I have to leave, Happy Thanksgiving to everyone.

AnCan – rick (to Everyone): 5:51 PM: Same to you Walt – tx for coming

AnCan – rick (to Everyone): 5:52 PM: where else can you hear two guys speak with so much chemo under their belt!?!

Joel Blanchette, Reston VA (Private): 5:54 PM: OK

Stephen Saft (to Everyone): 5:55 PM: I have a friend who has PSA in the 1500-2500 range. He has had few symptoms of the disease and no metastatic disease.

Pat Martin (to Everyone): 5:57 PM: Ya’all have a great Thanksgiving. Gonna run. See you next week

AnCan – rick (to Jim Ward): 6:08 PM: I’m telling Alexa that your pussy cat showed up on the call

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 23, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 15, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 15, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 23, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 9, 2021

Hi-Risk/Recurrent/Advanced PCa Video Chat, Nov 9, 2021

All AnCan’s groups are free and drop-in – join us in person sometime! You can find out more about this and our other 10 monthly prostate cancer groups at https://ancan.org/prostate-cancer/

To sign up to receive a weekly Reminder/Newsletter for this Group or others, go to https://ancan.org/contact-us/

Editor’s Pick: The importance of having a GU Med Onc (genitourinary medical oncologist) comes up more than once. And keep good records!(rd)

Topics Discussed

If chemo didn’t do the trick….; uncertain if trial is effective; draft a GU med onc – quickly!; 3 yrs off HT and treatment holding; in the midst of Provenge; the importance of good record keeping; PSAMA baseline scan; the PROMISE germline trial

Chat Log

Edward Clautice (to Everyone): 4:15 PM: 3/29/201 PSA 8.9 5/6/201 Biopsy 8 cores Gleasons range from 3+3 to 4+5.  Average Gleason 7.5. Also has perineural invasion

6/29/2015 Urologist removers prostate and some associated nerve (the one which controls erections) are removed at surgery; Inova Hospital Fairfax VA Lymph nodes biopsied. 0/3 with cancer Seminal vesicles are involved Prostate. Gleason 4+5 Positive margins seen. Tumor volume 70%

7/30/2015 – 10/?/2015

Begin radiation treatments of the prostate bed Receive a whole bunch of radiation. Doc says, never again get radiation there.

10/16/2015 PSA 0.4

1/28/16 Switched to Dr J Aragon-Ching, Oncologist PSA –  <0.1 Also receive Lupron Testosterone 6 ng/L

5/15/2018 Continue with DR Aragon-Ching getting Lupron and generally getting <0.1 on PSA

5/15/2018

Move from Fairfax to central Kentucky Sign up with Dr. Monte Metcalf. Regular oncologisy at regular hospital

8/?/2018 PSA begins to rise. Not sure how high. Begin Casodex. PSA drops

12/?/2019 PSA now rising again Switched over to Abiraterone. Dr Metcalfe seems not as concerned as I am . Abiraterone works for maybe 6 months

6/?/2020 PSA begins to rise again I decide to switch over to that giant teaching hospital (U of Kentucky) I keep driving past. Also  I now have much better medical insurance so I actually can switch over.

11/2/2020 PET scans, CT scans, every other kind of scan Lots of bone tumors, not a lot of soft tissue tumors (there were some reasons for this next delay, and honestly I forget exactly what they were) A couple times Dr PW takes my scans to the weekly med school oncology faculty meeting. “Tumor of the week club.”

2/?/2021 Bone biopsy. Shows tumors to be metastatic. PSA running about 7; which Dr PW says is really low compared to the tumor mass I have. Dr PW has senior UK pathologist personally check biopsies to make sure it is prostate cancer and not “small cell.” Senior pathologist confirms this is true.

4/15/2021 +/- Stop abiraterone Begin Docetaxel every 3 weeks, for 10 treatments Zoledonic acid (?for bones) every 6 weeks and keep getting anti-hormone shot, elegard , every 12 weeks Also prednisone PSA 7.11 I am allergic to docetaxel and it tries to stop me from breathing. Docs give me stuff so this does not happen any more. Minimal side effects that stop me from wanting to get more treatments of docetaxel

8/12/21 PSA 4.88

11/3/2021 Docs just posted results of yesterday’s CT scans and nuclear medicine scans PSA 3.7 Scans show no soft tissue tumors Scans show lots of widespread bone tumors. “Impression: Widespread bone metastases.” “New subtle foci of….” 4 or 5 places “Bones/joints: Focal mildly intense increased uptake involving……” a four line list of different bones. “Compared to previous: Progressive bone metastases.

11/4/2021 Get last docetaxel Talk with Dr PW about what comes next

Note: Up to this time I have zero symptoms of pain from tumors or anything else in my bones. I exercise and lift weights regularly.

Vic (to Organizer(s) Only): 4:32 PM: Is sequencing of tumor the way to determine if the cancer as advanced from MSPC to MRPC?

Vic (to Organizer(s) Only): 4:34 PM: Are any LU-177 trails open to MSPC?

Len Sierra (to Everyone): 4:42 PM: Vic, no, sequencing is done to see if there are mutations for which there are therapies that target that mutation.

AnCan – rick (to Vic): 4:44 PM: Vic ….. PSA rising is the sign of hormone resistance.   The only trial available to HSPC requires no prior hormone therapy

Jake (to Organizer(s) Only): 5:07 PM: No, I checked. It actually recorded 49 seconds including my apologies and the discussion about logging off and back on. Weird! You made the right decision since it is too undependable …

Vic (to Organizer(s) Only): 5:14 PM: what is bi-polar androgen therapy? Eligard plus Abiraterone?

Joe (to Everyone): 5:18 PM: gotta run gents, great to see y’all again

Rusty (Private): 5:23 PM: BBL have another meeting going on.

Len Sierra (to Everyone): 5:23 PM: Carlos, this comes from the Provenge Treatment Guide:              How to Prepare:

  • Stay hydrated by drinking more water in the days leading up to your

appointment

  • Avoid caffeinated beverages on the day of your appointment
  • Eat calcium-rich foods such as dairy products, dark leafy greens, or

supplements

  • Eat a hearty meal within four hours of your appointment
  • Wear loose-fitting clothes, with sleeves that can be raised above the elbow
  • Bring a current photo ID
  • Consider arranging transportation to and from the procedure

eric  (to Everyone): 5:24 PM: ok thanks you.

eric  (to Everyone): 5:27 PM: hey rick in order to particoate in the trail you sent me. Are you saying if I was still on the Orgovyx. I would be eligible for the Netashim trial?

AnCan – rick (to eric ): 5:27 PM: If me I would consider getting back on an LHRH drug like orgovyx ASAP. If not orgovyx or firmnagon, then be sure they give you at least 15 days of bicalutamide first. Some docs forget! you don’t nbeed with Orgo or Firma. Put pressure on them to give youa  quick appt. You don’t need Song now you need a GU (genitourinary) medical oncologist

Herb Geller (to Everyone): 5:29 PM: Actually, one other person at Hopkins is Catherine Handy Marshall.  She is an Antanorakis understudy and I think Carl saw her.

AnCan – rick (to eric ): 5:29 PM: Eric – if you were still on Orgovyx AND your PSA was rising you would be eligible.

Carl Forman (to Everyone): 5:29 PM: Yes I did see her; impressive.

AnCan – rick (to eric ): 5:31 PM: So here’s another name above. Catherine Handy Marshall

Pat Martin (to Everyone): 5:33 PM: See ya all next Monday.

Herb Geller (to Everyone): 5:37 PM: https://www.hopkinsmedicine.org/profiles/details/catherine-handy

Frank Fabish (to Everyone): 5:39 PM: Got to go guys. Thanks

AnCan – rick (to Everyone): 5:47 PM: https://www.fiercehealthcare.com/tech/invitae-scoops-up-consumer-health-tech-firm-ciitizen-for-325m  Bought by Invitae

AnCan – rick (to Vic): 5:50 PM: Vic …. are you any realtion to Lauren Paglisotti? We spoke to her at Michael J Fox

Len Sierra (to Everyone): 5:52 PM: That’s the goal of most startups — get bought out by a larger compary and cash in!

Vic (to Everyone): 5:57 PM: Thanks all!

Carlos Huerta (to Everyone): 6:00 PM: Good night all

AnCan – rick (to Everyone): 6:08 PM: Gotta run over to te RMCmeeting.G’night Gents

Special Presentation: Exercise After Prostate Cancer: Active Surveillance and Beyond

Special Presentation: Walking Around With Cancer: The Psychological Burden of Active Surveillance

On November 3rd, we had Dr. Andrew Matthew (Senior Psychologist, Co-Lead, GU Survivorship Program
Princess Margaret Cancer Centre) give a talk to our AS group titled “Walking Around With Cancer: The Psychological Burden of Active Surveillance

 

For over 20 years at Princess Margaret, Dr. Matthew’s clinical care and research has focused on urologic cancers, including prevention, treatment decision-making, sexual rehabilitation, survivorship, and patient quality of life.

 

Watch here:

 

To view the slides from this presentation, click here.

For information on our peer-led video chat ACTIVE SURVEILLANCE PROSTATE CANCER VIRTUAL SUPPORT GROUP, click here.

To SIGN UP for the Group or any other of our AnCan Virtual Support groups, visit our Contact Us page.